Frontiers in Pharmacology | Inflammation Pharmacology

Original Research

Published on 19 Apr 2023

Positive allosteric adenosine A2A receptor modulation suppresses insomnia associated with mania- and schizophrenia-like behaviors in mice

in Inflammation Pharmacology

Yang Lin
Koustav Roy
Shuji Ioka
Rintaro Otani
Mao Amezawa
Yukiko Ishikawa
Yoan Cherasse
Mahesh K. Kaushik
Daniela Klewe-Nebenius
Li Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1138666

5,346 views
7 citations

Original Research

Published on 18 Apr 2023

Lycium barbarum polysaccharide alleviates dextran sodium sulfate-induced inflammatory bowel disease by regulating M1/M2 macrophage polarization via the STAT1 and STAT6 pathways

in Inflammation Pharmacology

Juan Wang
Huiying Gao
Yuan Xie
Peng Wang
Yu Li
Junli Zhao
Chunlin Wang
Xin Ma
Yuwen Wang
Qinwen Mao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1044576

5,495 views
20 citations

Systematic Review

Published on 18 Apr 2023

Efficacy and safety of Omega-3 polyunsaturated fatty acids in adjuvant treatments for colorectal cancer: A meta-analysis of randomized controlled trials

in Inflammation Pharmacology

Haoshuang Liu
Jingfeng Chen
Weihao Shao
Su Yan
Suying Ding

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1004465

5,430 views
11 citations

Original Research

Published on 12 Apr 2023

Anti-hyperuricemia effect of hesperetin is mediated by inhibiting the activity of xanthine oxidase and promoting excretion of uric acid

in Inflammation Pharmacology

Meng-Fei An
Chang Shen
Shao-Shi Zhang
Ming-Yue Wang
Ze-Rui Sun
Mao-Si Fan
Li-Juan Zhang
Yun-Li Zhao
Jun Sheng
Xuan-Jun Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1128699

5,918 views
21 citations

Clinical Trial

Published on 11 Apr 2023

Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in obese patients with type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial

in Inflammation Pharmacology

Eman El-Khateeb
Eman I. El-Berri
Esraa M. Mosalam
Mohamed Z. Nooh
Shimaa Abdelsattar
Amira M. Alghamdi
Sarah Alrubia
Mahmoud S. Abdallah

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1153653

9,339 views
6 citations

Original Research

Published on 11 Apr 2023

Single-cell transcriptomics reveals immune infiltrate in sepsis

in Inflammation Pharmacology

Xusheng Tu
He Huang
Shilei Xu
Caifei Li
Shaoning Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1133145

7,543 views
12 citations

Original Research

Published on 10 Apr 2023

Sirtuin 1 activator alleviated lethal inflammatory injury via promotion of autophagic degradation of pyruvate kinase M2

in Inflammation Pharmacology

Shuang Zhao
Yili Sun
Xicheng Wu
Yongqiang Yang
Kerui Fan
Kai Hu
Yasha Qin
Kexin Li
Ling Lin
Kun Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1092943

3,124 views
5 citations

Review

Published on 06 Apr 2023

Potential of resveratrol in the treatment of interstitial lung disease

in Inflammation Pharmacology

Rongxiu Huo
Xinxiang Huang
Yanting Yang
Yang Yang
Jinying Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1139460

5,502 views
11 citations

Review

Published on 06 Apr 2023

PGC-1α in osteoarthritic chondrocytes: From mechanism to target of action

in Inflammation Pharmacology

Haochen Wang
Jianbang Su
Minghao Yu
Yang Xia
Yingliang Wei

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1169019

7,105 views
11 citations

Correction

Published on 05 Apr 2023

Corrigendum: Improved diagnosis of inflammatory bowel disease and prediction and monitoring of response to anti-TNF alpha treatment based on measurement of signal transduction pathway activity

in Inflammation Pharmacology

Wilbert Bouwman
Wim Verhaegh
Anja van de Stolpe

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1183639

1,030 views
1 citation

Original Research

Published on 29 Mar 2023

Lipidome remodeling activities of DPA-EA in palmitic acid-stimulated HepG2 cells and the in vivo anti-obesity effect of the DPA-EA and DHA-EA mixture prepared from algae oil

in Inflammation Pharmacology

Hua Fang
Yin Cao
Jianyu Zhang
Xiumei Wang
Mengyu Li
Zhuan Hong
Zhen Wu
Meijuan Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1146276

4,414 views
12 citations

Correction

Published on 29 Mar 2023

Corrigendum: Induced expression of kir6.2 in A1 astrocytes propagates inflammatory neurodegeneration via Drp1-dependent mitochondrial fission

in Inflammation Pharmacology

Nanshan Song
Hong Zhu
Rong Xu
Jiaqi Liu
Yinquan Fang
Jing Zhang
Jianhua Ding
Gang Hu
Ming Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1111925

1,252 views
1 citation

Editorial

Published on 24 Mar 2023

Editorial: Streaming inflammation: From damage to healing and resilience–Volume II

in Inflammation Pharmacology

Pallavi R. Devchand
Eric E. Schadt
Garret A. FitzGerald

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1185593

1,706 views

Original Research

Published on 23 Mar 2023

Analysis of networks in the dorsolateral prefrontal cortex in chronic schizophrenia: Relevance of altered immune response

in Inflammation Pharmacology

América Vera-Montecinos
Ricard Rodríguez-Mias
Èlia Vila
Judit Villén
Belén Ramos

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1003557

3,365 views
1 citation

Editorial

Published on 20 Mar 2023

Editorial: Inflammation and immune diseases: Molecular targets for pathogenesis and treatment

in Inflammation Pharmacology

Fan-Rong Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1174965

1,596 views

Original Research

Published on 20 Mar 2023

Chrysin ameliorates synovitis and fibrosis of osteoarthritic fibroblast-like synoviocytes in rats through PERK/TXNIP/NLRP3 signaling

in Inflammation Pharmacology

Liang Ding
Taiyang Liao
Nan Yang
Yibao Wei
Runlin Xing
Peng Wu
Xiaochen Li
Jun Mao
Peimin Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1170243

5,765 views
22 citations